SurvivorNet on MSN6mon
What to Know About CDK4/6 Inhibitors as Breast Cancer Treatment: Weighing the Risks vs. Benefits
It appears to affect the CDK4 protein more than the CDK6 protein. Ibrance and Kisqali affect both CDK4 and CDK6 and have to ...
Hosted on MSN1mon
Approved drug dronedarone found to inhibit the proliferation of esophageal squamous cell carcinoma
In this context, a study appearing in Frontiers of Medicine explores the potential of dronedarone, an FDA-approved drug, in inhibiting ESCC proliferation through the CDK4/CDK6-RB1 axis ...
Nature3y
The classical and minimal models of cell cycle control
(B) CDK1 and CDK2 bind to multiple cyclins (cyclin types A, B, D and E), whereas CDK4 and CDK6 only partner D-type cyclins. Thick lines represent the preferred pairing for each kinase. (C ...